Expression profiling of melanoma cell lines: in search of a progression-related molecular signature.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Molecular pathology of cutaneous melanoma.Melanoma management · 2014
   Review
2. Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?Journal of skin cancer · 2011
   Article
3. New Perspectives of "omics" Applications in Melanoma Research.The open biochemistry journal · 2011
   Article
4. Variability in melanoma metalloproteinase expression profiling.Journal of biomolecular techniques : JBT · 2010
   Article
5. Biomarkers in melanoma.Annals of oncology : official journal of the European Society for Medical Oncology · 2009
   Review
6. Gene expression signature for spontaneous cancer regression in melanoma pigs.Neoplasia (New York, N.Y.) · 2008
   Article

Corrections and comments

• Comment on
  Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression.2007

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.